Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial
Open Access
- 17 September 2021
- journal article
- research article
- Published by Springer Nature in npj Digital Medicine
- Vol. 4 (1) , 1-8
Abstract
People with diabetes (PWD) have an increased risk of developing influenza-related complications, including pneumonia, abnormal glycemic events, and hospitalization. Annual influenza vaccination is recommended for PWD, but vaccination rates are suboptimal. The study aimed to increase influenza vaccination rate in people with self-reported diabetes. This study was a prospective, 1:1 randomized controlled trial of a 6-month Digital Diabetes Intervention in U.S. adults with diabetes. The intervention group received monthly messages through an online health platform. The control group received no intervention. Difference in self-reported vaccination rates was tested using multivariable logistic regression controlling for demographics and comorbidities. The study was registered at clinicaltrials.gov: NCT03870997. A total of 10,429 participants reported influenza vaccination status (5158 intervention, mean age (±SD) = 46.8 (11.1), 78.5% female; 5271 control, Mean age (±SD) = 46.7 (11.2), 79.4% female). After a 6-month intervention, 64.2% of the intervention arm reported influenza vaccination, vers us 61.1% in the control arm (diff = 3.1, RR = 1.05, 95% CI [1.02, 1.08], p = 0.0013, number needed to treat = 33 to obtain 1 additional vaccination). Completion of one or more intervention messages was associated with up to an 8% increase in vaccination rate (OR 1.27, 95% CI [1.17, 1.38], p < 0.0001). The intervention improved influenza vaccination rates in PWD, suggesting that leveraging new technology to deliver knowledge and information can improve influenza vaccination rates in high-risk populations to reduce public health burden of influenza. Rapid cycle innovation could maximize the effects of these digital interventions in the future with other populations and vaccines.Keywords
Funding Information
- Sanofi
This publication has 28 references indexed in Scilit:
- Estimates of global seasonal influenza-associated respiratory mortality: a modelling studyThe Lancet, 2018
- Acute Myocardial Infarction after Laboratory-Confirmed Influenza InfectionNew England Journal of Medicine, 2018
- Benefits of flu vaccination for persons with diabetes mellitus: A reviewVaccine, 2017
- Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7years follow up studyVaccine, 2017
- Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetesCanadian Medical Association Journal, 2016
- Using physician billing claims from the Ontario Health Insurance Plan to determine individual influenza vaccination status: an updated validation studyCMAJ Open, 2016
- The antibody response to influenza vaccination is not impaired in type 2 diabeticsVaccine, 2015
- Medicare Claims Versus Beneficiary Self-Report for Influenza Vaccination SurveillanceAmerican Journal of Preventive Medicine, 2015
- Planning prompts as a means of increasing preventive screening ratesPreventive Medicine, 2013
- Diabetes and the Severity of Pandemic Influenza A (H1N1) InfectionDiabetes Care, 2010